HWAIF Stock Chart & Stats
$0.56
$0.01(2.41%)
At close: 4:00 PM EDT
$0.56
$0.01(2.41%)
Day’s Range― - ―
52-Week Range$0.39 - $1.21
Previous CloseN/A
Volume18.56K
Average Volume (3M)27.39K
Market Cap
$188.67M
Enterprise Value$287.49
Total Cash (Recent Filing)$39.81M
Total Debt (Recent Filing)$84.51M
Price to Earnings (P/E)―
Beta1.41
Next Earnings
Nov 16, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding304,754,880
10 Day Avg. Volume33,997
30 Day Avg. Volume27,387
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.70
Price to Sales (P/S)2.03
P/FCF Ratio-10.44
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$1.32Price Target Upside135.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)-0.04
Revenue Forecast (FY)$97.94M
Bulls Say, Bears Say
Bulls Say
Strong Revenue Scale-upThe substantial year-to-date revenue increase expands HEALWELL AI’s operating base and supports greater scale across its healthcare technology portfolio. Although Orion contributed materially, the larger platform creates more opportunities for cross-selling, recurring contracts, and improved operating leverage.
Large Clinical Data And Provider NetworkBroad access to patient records, clinicians, providers, and AI-copilot users can strengthen HEALWELL AI’s market position and improve the usefulness of its clinical analytics. DARWEN’s screening reach also provides measurable evidence that the platform is deployed at meaningful healthcare scale.
Improving Operating PerformanceThe move to positive first-half operating cash flow and sharply higher adjusted EBITDA indicates meaningful progress in operating efficiency and earnings quality. If sustained as the business scales, this improvement could reduce funding pressure and support investment in product development and enterprise expansion.
Bears Say
Persistent Losses And Negative Free Cash FlowHEALWELL AI has not yet demonstrated durable profitability or self-funding operations, despite recent improvements. Continued net losses and negative trailing free cash flow can constrain investment flexibility, increase reliance on external capital, and make execution more sensitive to delays in enterprise revenue conversion.
Long Enterprise Sales Cycles Delay GrowthLong sales cycles create a structural timing risk for a company transitioning toward larger recurring enterprise contracts. Delayed decisions and implementation milestones can defer revenue recognition, make quarterly results uneven, and postpone the operating leverage expected from the enterprise model.
Integration And Margin Synergies Remain IncompleteThe remaining integration work means the expected profitability benefits from Orion have not yet fully reached the income statement. Technology-debt reduction, R&D consolidation, and cost synergies may require sustained execution, leaving margins exposed while the company completes this transition.
HEALWELL AI News
HWAIF FAQ
What was HEALWELL AI’s price range in the past 12 months?
HEALWELL AI lowest stock price was $0.39 and its highest was $1.21 in the past 12 months.
What is HEALWELL AI’s market cap?
HEALWELL AI’s market cap is $188.67M.
When is HEALWELL AI’s upcoming earnings report date?
HEALWELL AI’s upcoming earnings report date is Nov 16, 2026 which is in 45 days.
How were HEALWELL AI’s earnings last quarter?
HEALWELL AI released its earnings results on Aug 07, 2026. The company reported $0.014 earnings per share for the quarter, beating the consensus estimate of -$0.018 by $0.032.
Is HEALWELL AI overvalued?
According to Wall Street analysts HEALWELL AI’s price is currently Undervalued.
Does HEALWELL AI pay dividends?
HEALWELL AI does not currently pay dividends.
What is HEALWELL AI’s EPS estimate?
HEALWELL AI’s EPS estimate is -0.02.
How many shares outstanding does HEALWELL AI have?
HEALWELL AI has 304,754,880 shares outstanding.
What happened to HEALWELL AI’s price movement after its last earnings report?
HEALWELL AI reported an EPS of $0.014 in its last earnings report, beating expectations of -$0.018. Following the earnings report the stock price went down -2.045%.
Which hedge fund is a major shareholder of HEALWELL AI?
Currently, no hedge funds are holding shares in HWAIF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HEALWELL AI Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$1.32 (135.32% Upside)
$1.32 (135.32% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.75%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-10.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
HEALWELL AI
Healwell AI Inc., a Toronto-based healthcare technology firm established in 2012, specializes in leveraging artificial intelligence and data science to advance preventative medical care. The company develops an AI-powered platform designed to assist healthcare providers with crucial decision-making. They maintain a significant strategic partnership with WELL Health Technologies Corp., focusing on accelerating the expansion and innovation of AI-driven healthcare solutions. Prior to its current name, adopted in October 2023, the organization was known as MCI Onehealth Technologies Inc.
HWAIF Stock 12 Month Forecast
Average Price Target
$1.32
▲(135.32% Upside)
Technical Analysis
Cardiocomm Solutions
―
Reliq Health Technologies
―
Leveljump Healthcare Corp.
―
Kovo HealthTech Corporation
―
Hydreight Technologies Inc
―
Ownership Overview
12.61% Insiders
<0.01% Other Institutional Investors
87.38% Public Companies and
Individual Investors